FERMENTABSEFermenta Biotech LtdLowNeutral
Announced Tue, 12 Aug · 23:26 IST

73rd Annual General Meeting - Scrutinizer report

Board & Shareholder Meetings View source PDF

FERMENTA · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve

Awaiting price reaction for this filing.

AI summary

Fermenta Biotech held its 73rd Annual General Meeting on August 12, 2025 via video conferencing, with 13,203 members on the cut-off date (August 6, 2025). All 13 resolutions were passed with overwhelming majority, including adoption of FY25 audited financial statements and declaration of a dividend of Rs. 2.50 per equity share (50% on face value of Rs. 5). Shareholders also approved the new 'Fermenta Biotech Limited – Employee Stock Option Scheme 2025' along with related proposals for granting options to subsidiary employees, secondary acquisition via trust route, and provision of funds for trust purchases of own shares. Re-appointments of Mr. Satish Varma and Ms. Anupama Datla Desai as Executive Directors for 3 years were approved. Material Related Party Transactions (promoter group interested) and commission to Non-Executive Directors were also cleared. Total votes polled across resolutions ranged from about 8.4% to 73.1% of outstanding shares, with 'against' votes being negligible.

Likely market impact

Routine procedural outcome – all resolutions passed comfortably. Confirms a Rs. 2.50/share dividend for FY25 and greenlights the new ESOP 2025 scheme, which could lead to minor share dilution over time. No material governance red flags as dissent was minimal (less than 0.05% on any resolution).